4//SEC Filing
Burrows Scott L 4
Accession 0001567619-23-004270
CIK 0001787306other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:05 PM ET
Size
8.9 KB
Accession
0001567619-23-004270
Insider Transaction Report
Form 4
Burrows Scott L
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-02-28$16.17/sh−416$6,725→ 39,840 total - Sale
Common Stock
2023-03-02$15.82/sh−1,416$22,399→ 38,424 total - Sale
Common Stock
2023-03-02$16.52/sh−18$297→ 38,406 total
Footnotes (3)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]The transaction was executed in multiple trades in prices ranging from $15.990 to $16.320, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The transaction was executed in multiple trades in prices ranging from $15.470 to $16.460, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001853327
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:05 PM ET
- Size
- 8.9 KB